Ryman Healthcare enjoyed its best week in almost two years.
NZ-founded, ASX-listed chemicals group has lost its third director post-IPO.
Initial reaction strongly negative as market digests risks of Australian leaky pipes problem.
Insurance company’s underlying profit expected to be between $7m and $10m, including large events.
In a 90-minute presentation CEO Ross Taylor rebuts claims a faulty product is behind bursting pipes in WA, blaming problems on faulty installation.
Offshore private equity player seems most likely, Sky-watchers suggest, as company stabilises its performance.
Fletcher has placed its shares in trading halt as it prepares a response to an expert report on leaky pipes in Australia – information it appears to have had since June.
Mystery of why the company's share buyback has been paused since May is solved, at least.
Airline says domestic travel market has been ‘soft’, while fuel prices hamper performance.
Complete remediation of all properties affected could cost A$1.8b, says WA building group.
